Skip to content

Phenylephrine Versus Tranexamic Acid to Control Bleeding in Patients Undergoing Inferior Turbinoplasty by Coblation

Phenylephrine Versus Tranexamic Acid to Control Bleeding in Patients Undergoing Inferior Turbinoplasty by Coblation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05841251
Enrollment
80
Registered
2023-05-03
Start date
2023-05-01
Completion date
2023-12-01
Last updated
2023-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coblation Turbinoplasty, Intraoperative Bleeding

Brief summary

Coblation is a unique method of delivering radio frequency energy to the soft tissue for applications in otolaryngology. It induces reduction of the inferior turbinate by vaporizing and destroying the soft erectile tissue. The volume reduction and tissue fibrosis are immediate and sustainable. Bleeding from the vascular capillary beds of the sinonasal mucosa compromises the surgical field and increases operative time and risk of complications. In this study we try to assist hemostasis with a multifaceted approach, including use of topical vasoconstrictors phenylephrine and systemic antifibrinolytic agent tranexamic acid.

Interventions

phenylephrine-soaked pack using the whole 5 ml of the solution provided with.5% phenylephrine will be applied after induction of surgery and intubation, 15 minutes before surgery. 100 ml of normal saline will be given.

DRUGintravenous tranexamic acid

patients will receive intravenous Single dose of tranexamic acid 15 mg/kg in 100 mL normal saline over 10 minutes. Saline-soaked pack will be applied.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists (ASA) physical status I and II * Scheduled patients for Coblation Turbinoplasty surgery with inferior turbinate hypertrophy

Exclusion criteria

* Known allergy to study drugs. * History of coagulopathy or bleeding disorders. * Patients with hypertension or ischemic heart disease. * patients on anticoagulants, antiplatelets or NSAIDs * history of deep vein thrombosis, stroke or peripheral vascular disease.

Design outcomes

Primary

MeasureTime frameDescription
surgical field scaleintraoperativelthe intraoperative surgical site bleeding using the surgical field scale as follows: 0 = No bleeding 1. = Minimal bleeding: Not a surgical nuisance and no suction required 2. = Mild bleeding: Occasional suction required, but does not affect dissection 3. = Moderate bleeding: Slightly compromises surgical field, frequent suction required 4. = Severe bleeding: Significantly compromises surgical field, frequent suction required, bleeding threat field just after removal of suction 5. = Massive bleeding: Prevent dissection.

Secondary

MeasureTime frameDescription
Volume of Blood lossintraoperative
Duration of surgerythe duration from induction of anesthesia till extubation
Avoidance of postoperative nasal packingimmediately after the surgeyif the patient can be spared from postoperatiove nasal pack inserted for controllling bleeding
Intra-operative and Postoperative complicationsintraoperative and 24 hours postoperativeComplications such as nausea, vomiting, hypotnsion, hypertension, hemorraghic or thrombotic manifestations for 24 hours

Contacts

Primary ContactAhmed A Mohammed, M.D.
ahmedfotoh86@aun.edu.eg01060757593

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026